ZNA Stuivenberg / MSOC Free Clinic
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bourgeois, Stefan
NCT05276297: A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

Active, not recruiting
2
184
Europe, RoW
GSK3228836, Bepirovirsen, GSK3528869A, Control
GlaxoSmithKline
Hepatitis B, Chronic
02/26
02/26
NCT03866187: Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Active, not recruiting
1/2
148
Europe, RoW
ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation, HBc-HBs/AS01B-4 low dose formulation, HBc-HBs/AS01B-4 high dose formulation, MVA-HBV low dose formulation, MVA-HBV high dose formulation, Placebo
GlaxoSmithKline
Hepatitis B, Chronic
10/25
10/25
REINF_HCV, NCT04251572: HCV Reinfection After DAA Therapy in PWID in Belgium

Recruiting
N/A
100
Europe
Blood sampling, questionaires
Hasselt University, Ziekenhuis Oost-Limburg, Jessa Hospital, Algemeen Ziekenhuis Vesalius, CAD Limburg, Sint-Trudo, Free Clinic Antwerp, Ziekenhuis Netwerk Antwerpen (ZNA), Clinique Saint Joseph, Liège, Centre Hospitalier Universitaire Saint Pierre, Algemeen Ziekenhuis Maria Middelares
Hepatitis C Virus Infection, Response to Therapy of, Drug Use
02/22
02/22
COIN-B, NCT04779970 / 2019-001226-10: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections

Active, not recruiting
N/A
156
Europe
Cessation of ongoing treatment
University Hospital, Antwerp, Universiteit Antwerpen
Chronic Hepatitis B
12/25
12/25
Mathei, Catharina
No trials found

Download Options